文献速递肿瘤 PET/CT核素与放射性配体治疗

肾上腺Castleman病的99mTc-HYNIC-TOC扫描与FDG PET/CT表现

Adrenal Castleman Disease on 99mTc-HYNIC-TOC Scan and FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2021-01-01

本文报道一例75岁男性右侧肾上腺肿物的99mTc-HYNIC-TOC扫描与FDG PET/CT影像表现。肿物99mTc-HYNIC-TOC活性明显升高,FDG活性亦显著,最初疑诊嗜铬细胞瘤,术后病理证实为肾上腺Castleman病。

要点

  • 肾上腺Castleman病极为罕见,可表现为99mTc-HYNIC-TOC摄取明显升高。
  • FDG PET/CT上FDG活性显著,易误诊为嗜铬细胞瘤等肾上腺肿瘤。
  • 最终诊断依赖手术切除标本的病理学检查。

核心结论

  • 肾上腺Castleman病在99mTc-HYNIC-TOC扫描和FDG PET/CT上均可表现为摄取增高,影像学易与嗜铬细胞瘤混淆,确诊需依靠病理。

研究设计与样本

  • 本文为个案报道,描述一例75岁男性右侧肾上腺肿物的99mTc-HYNIC-TOC扫描与FDG PET/CT影像表现。

主要发现

  • 右侧肾上腺肿物在99mTc-HYNIC-TOC扫描上活性明显升高。
  • 同一位患者FDG PET/CT上FDG活性显著。
  • 最初怀疑嗜铬细胞瘤,但切除标本病理显示为肾上腺Castleman病。

临床怎么用

  • 对肾上腺肿物进行核医学显像评估时,若99mTc-HYNIC-TOC与FDG均摄取增高,应将Castleman病纳入鉴别诊断。

局限性

  • 本文为单个病例报道,未提供样本量、定量阈值或随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Adrenal Castleman disease is very rare. We reported image findings of a right adrenal mass in a 75-year-old man on Tc-HYNIC-TOC scan and FDG PET/CT. There was obviously elevated Tc-HYNIC-TOC activity, but the intensity of FDG activity was remarkable. Pheochromocytoma was initially suspected. However, pathology from resected specimen showed adrenal Castleman disease.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Ding J, Cheng X, Hou G, et al. Adrenal Castleman Disease on 99mTc-HYNIC-TOC Scan and FDG PET/CT. Clin Nucl Med. 2021. PMID: 32956111. doi:10.1097/RLU.0000000000003271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。